0001567619-23-005926.txt : 20230508
0001567619-23-005926.hdr.sgml : 20230508
20230508103101
ACCESSION NUMBER: 0001567619-23-005926
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20230508
DATE AS OF CHANGE: 20230508
EFFECTIVENESS DATE: 20230508
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001070081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043416587
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-481052
FILM NUMBER: 23896373
BUSINESS ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
BUSINESS PHONE: 9082227000
MAIL ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
FORMER COMPANY:
FORMER CONFORMED NAME: PTC THERAPEUTICS INC
DATE OF NAME CHANGE: 19980909
D
1
primary_doc.xml
X0708
D
LIVE
0001070081
PTC THERAPEUTICS, INC.
100 CORPORATE COURT
SOUTH PLAINFIELD
NJ
NEW JERSEY
07080-2449
9082227000
DELAWARE
None
PTC THERAPEUTICS INC
Corporation
true
Matthew
B.
Klein, M.D.
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080
Executive Officer
Director
Dr. Klein is the Chief Executive Officer and the Director of the Development Committee of the Issuer.
Neil
Almstead, Ph.D
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080
Executive Officer
Dr. Almstead is the Chief Technical Operations Officer of the Issuer.
Mark
E.
Boulding
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080
Executive Officer
Mr. Boulding is the Executive Vice President and Chief Legal Officer of the Issuer.
Emily
Hill
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080
Executive Officer
Ms. Hill is the Chief Financial Officer of the Issuer.
Eric
Pauwels
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080
Executive Officer
Mr. Pauwels is the Chief Business Officer of the Issuer.
Christine
Utter
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080
Executive Officer
Ms. Utter is the Senior Vice President, Chief Accounting Officer and Head of People Services of the Issuer.
Stepanie
S.
Okey
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080
Director
Jerome
B.
Zeldis, M.D., Ph.D.
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080
Director
Emma
Reeve
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080
Director
Michael
Schmertzler
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080
Director
Glenn
D.
Steele Jr., M.D., Ph.D.
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080
Director
Mary
Smith
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080
Director
Allan
Jacobson, Ph.D.
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080
Director
David
P.
Southwell
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080
Director
Alethia
Young
c/o PTC Therapeutics, Inc.
100 Corporate Court
South Plainfield
NJ
NEW JERSEY
07080
Director
Biotechnology
Decline to Disclose
- 06b
false
2023-04-10
false
true
true
Common Stock
true
0
35897425
35897425
0
false
40
0
0
0
false
PTC THERAPEUTICS, INC.
/s/ Mark E. Boulding
Mark E. Boulding
Executive Vice President and Chief Legal Officer
2023-05-05